Boston Scientific Corporation (VIE:BSXC)

Market Cap	61.81B -52.8%
Revenue (ttm)	18.38B +13.5%
Net Income	3.22B +46.7%
EPS	2.16 +46.9%
Shares Out	n/a
PE Ratio	19.22
Forward PE	14.74
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	42.76
Previous Close	43.45
Day's Range	42.67 - 42.88
52-Week Range	37.24 - 92.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatogra...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1979
• Employees: 59,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: BSXC

Financial Performance

In 2025, Boston Scientific's revenue was $20.07 billion, an increase of 19.87% compared to the previous year's $16.75 billion. Earnings were $2.90 billion, an increase of 56.40%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 7, 2026

Data Sources Report a data error